DocGo (DCGO) Stock Price, News & Analysis

Company Overview

DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.

Key Stats

• Today's Range: $1.54 to $1.62
• 50-Day Range: $1.28 to $2.40
• 52-Week Range: $1.23 to $5.68
• Volume: 344,412 shs
• Average Volume: 766,546 shs
• Market Capitalization: $161.64 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $3.56
• Consensus Rating: Moderate Buy

DocGo Stock Analysis - MarketRank™

DocGo scored higher than 47% of companies evaluated by MarketBeat, and ranked 577th out of 929 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

DocGo has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 3 buy ratings, 3 hold ratings, and no sell ratings.

Amount of Analyst Coverage

DocGo has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: -68.00%

Earnings Growth

Earnings for DocGo are expected to decrease by -68.00% in the coming year, from $0.25 to $0.08 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of DocGo is -79.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of DocGo is -79.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

DocGo has a P/B Ratio of 0.51. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

7.01% of the float of DocGo has been sold short.

Short Interest Ratio / Days to Cover

DocGo has a short interest ratio ("days to cover") of 5.7.

Change versus previous month

Short interest in DocGo has recently increased by 21.37%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

DocGo does not currently pay a dividend.

Dividend Growth

DocGo does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

7.01% of the float of DocGo has been sold short.

Short Interest Ratio / Days to Cover

DocGo has a short interest ratio ("days to cover") of 5.7.

Change versus previous month

Short interest in DocGo has recently increased by 21.37%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: 0.93

News Sentiment

DocGo has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for DocGo this week, compared to 3 articles on an average week.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, DocGo insiders have bought more of their company's stock than they have sold. Specifically, they have bought $58,200.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

Only 2.70% of the stock of DocGo is held by insiders.

Percentage Held by Institutions

56.44% of the stock of DocGo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

DCGO Stock Analysis - Frequently Asked Questions

How have DCGO shares performed this year?

DocGo's stock was trading at $4.24 on January 1st, 2025. Since then, DCGO shares have decreased by 62.6% and is now trading at $1.5850.

How were DocGo's earnings last quarter?

DocGo Inc. (NASDAQ:DCGO) released its quarterly earnings data on Thursday, May, 8th. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.01) by $0.08. The business earned $96.03 million during the quarter, compared to the consensus estimate of $104.25 million. DocGo had a positive trailing twelve-month return on equity of 2.52% and a negative net margin of 0.12%.
Read the conference call transcript.

How do I buy shares of DocGo?

Shares of DCGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of DocGo own?

Based on aggregate information from My MarketBeat watchlists, some other companies that DocGo investors own include Meta Platforms (META), NVIDIA (NVDA), CrowdStrike (CRWD), Adobe (ADBE), Broadcom (AVGO), Arista Networks (ANET) and ServiceNow (NOW).

Company Calendar

• Last Earnings: 5/08/2025
• Today: 7/05/2025
• Next Earnings (Estimated): 8/06/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:DCGO
• CIK: 1822359
• Web: www.docgo.com
• Phone: 844-443-6246
• Fax: N/A
• Employees: 4,407
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $3.56
• High Stock Price Target: $5.50
• Low Stock Price Target: $1.45
• Potential Upside/Downside: +124.6%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.02)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 6.34
• P/E Growth: N/A
• Net Income: $19.99 million
• Net Margins: -0.12%
• Pretax Margin: -0.53%
• Return on Equity: 2.52%
• Return on Assets: 1.70%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.44
• Quick Ratio: 2.44

Sales & Book Value

• Annual Sales: $616.55 million
• Price / Sales: 0.26
• Cash Flow: $0.42 per share
• Price / Cash Flow: 3.74
• Book Value: $3.09 per share
• Price / Book: 0.51

Miscellaneous

• Outstanding Shares: 101,980,000
• Free Float: 99,229,000
• Market Cap: $161.64 million
• Optionable: Optionable
• Beta: 0.97